ALB and acute kidney injury: In patients with baseline serum albumin ≤3.3 g/dL, albumin treatment improved AKI regression and recovery compared to no albumin (Supplementary Table S12, p < 0.05), but this effect was not observed in those with baseline albumin >3.3 g/dL (Supplementary Table S12).